This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
2 Nov 2017

Mylan response to announcement of proposed amendments to civil complaint

Company says it has found "no evidence of price fixing on the part of Mylan or its employees".

Mylan has provided the following statement in response to the announcement of proposed amendments to the civil complaint by various states' attorneys general in multi-district litigation pending in the US District Court for the Eastern District of Pennsylvania against Mylan and 17 other pharmaceutical companies:

"We have been investigating these allegations thoroughly and have found no evidence of price fixing on the part of Mylan or its employees. Our review of the Connecticut Attorney General's press release underpinning the complaint does not change our views. We have asked the various attorneys general leading this case to share with us what information they believe supports these new allegations and, to date, they have not done so. Mylan has deep faith in the integrity of its President, Rajiv Malik, and stands behind him fully. Mylan and Rajiv Malik both intend to defend this case vigorously, and we look forward to the opportunity to present a full defense."

Mylan says it takes its legal obligations seriously and operates with the highest levels of integrity and character. The company expects to have no further comment while the matter is pending.

Related News